These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1523192)

  • 1. Recent developments in peptide drug delivery to the brain.
    Pardridge WM
    Pharmacol Toxicol; 1992 Jul; 71(1):3-10. PubMed ID: 1523192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of peptides and proteins through the blood-brain barrier.
    Bickel U; Yoshikawa T; Pardridge WM
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):247-79. PubMed ID: 11259843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cells.
    Kang YS; Voigt K; Bickel U
    J Drug Target; 2000; 8(6):425-34. PubMed ID: 11328668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Yoshikawa T; Pardridge WM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
    Wu D; Boado RJ; Pardridge WM
    J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain drug targeting and gene technologies.
    Pardridge WM
    Jpn J Pharmacol; 2001 Oct; 87(2):97-103. PubMed ID: 11700018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.
    Saito Y; Buciak J; Yang J; Pardridge WM
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10227-31. PubMed ID: 7479757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.
    Pardridge WM; Kang YS; Buciak JL
    Pharm Res; 1994 May; 11(5):738-46. PubMed ID: 8058646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier.
    Pardridge WM; Kumagai AK; Eisenberg JB
    Biochem Biophys Res Commun; 1987 Jul; 146(1):307-13. PubMed ID: 2955786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration.
    Pardridge WM; Wu D; Sakane T
    Pharm Res; 1998 Apr; 15(4):576-82. PubMed ID: 9587954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody.
    Pardridge WM
    Expert Opin Drug Deliv; 2015 Feb; 12(2):207-22. PubMed ID: 25138991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier.
    Zlokovic BV
    Pharm Res; 1995 Oct; 12(10):1395-406. PubMed ID: 8584471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vector-mediated drug delivery to the brain.
    Pardridge WM
    Adv Drug Deliv Rev; 1999 Apr; 36(2-3):299-321. PubMed ID: 10837722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain.
    Pardridge WM; Triguero D; Buciak JL
    Endocrinology; 1990 Feb; 126(2):977-84. PubMed ID: 2137082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
    Bickel U; Yoshikawa T; Landaw EM; Faull KF; Pardridge WM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2618-22. PubMed ID: 8385339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid peptide drug development: transport of opioid chimeric peptides through the blood-brain barrier.
    Pardridge WM
    NIDA Res Monogr; 1992; 120():153-68. PubMed ID: 1501684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vector-mediated peptide drug delivery to the brain.
    Pardridge WM
    Adv Drug Deliv Rev; 1995 Jul; 15(1-3):109-146. PubMed ID: 35524386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
    Kang YS; Pardridge WM
    J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker.
    Deguchi Y; Kurihara A; Pardridge WM
    Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.